David Grunig
Basel, BS 4003, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Non-viral gene delivery of the oncotoxic protein NS1 for treatment of hepatocellular carcinoma.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 28, 2020
Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms.
Journal: Biochemical pharmacology
Published: October 21, 2019
Acute Liver Failure in a Patient Treated With Metamizole.
Journal: Frontiers in pharmacology
Published: May 21, 2019
Effect of the Catechol-O-Methyltransferase Inhibitors Tolcapone and Entacapone on Fatty Acid Metabolism in HepaRG Cells.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: April 25, 2018
Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.
Journal: Frontiers in pharmacology
Published: October 20, 2017
Mechanisms of mitochondrial toxicity of the kinase inhibitors ponatinib, regorafenib and sorafenib in human hepatic HepG2 cells.
Journal: Toxicology
Published: October 19, 2017
The catechol-O-methyltransferase inhibitors tolcapone and entacapone uncouple and inhibit the mitochondrial respiratory chain in HepaRG cells.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: February 08, 2017
Hepatic Effects of Pharmacological Doses of Hydroxy-Cobalamin[c-lactam] in Mice.
Journal: PloS one
Published: September 28, 2016
Impaired mitochondrial function in HepG2 cells treated with hydroxy-cobalamin[c-lactam]: A cell model for idiosyncratic toxicity.
Journal: Toxicology
Published: May 06, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026